US 10329563
Organic compositions to treat HSF1-related diseases
granted A61KA61K31/5377A61K31/713
Quick answer
US patent 10329563 (Organic compositions to treat HSF1-related diseases) held by Arrowhead Pharmaceuticals, Inc. expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/5377, A61K31/713, A61K45/06, A61P